# Blue Sail Medical to invest up to CNY 2.48B in Shanghai R&D headquarters and production base

Blue Sail Medical plans to invest up to CNY 2.48 billion to build a science and innovation headquarters and industrialization base in Shanghai International Medical Zone, Shanghai, for global commercial headquarters and high-value medical device production.

- Type: New facility
- Announced: 2022-12-13
- Where: Shanghai International Medical Zone, Shanghai, China
- Value: $356.0M (2.48B CNY)
- Status: announced
- Products: coronary intervention devices, structural heart disease devices, peripheral intervention devices, neurointervention devices, minimally invasive surgical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Blue Sail Medical](https://endata.com/companies/47769.md)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/846808.html), 2022-12-13: "公司拟在上海市浦东新区上海国际医学园区投资建设蓝帆医疗科创总部及产业化基地项目，用于蓝帆医疗全球商业总部及高值产医疗器械生产基地"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.